Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSONG.L Regulatory News (SONG)

  • There is currently no data for SONG

Increased Debt Facility

23 Jul 2020 07:00

RNS Number : 8665T
Hipgnosis Songs Fund Limited
23 July 2020
Β 

23 July 2020

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Increased Debt Facility

The Board of Hipgnosis , the first and only UK listed investment company offering investors a pure-play exposure to songs and associated intellectual property rights, and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has entered into an agreement with a syndicated group of lenders, with JPMorgan Chase Bank as Lead Arranger, to increase its Revolving Credit Facility from Β£150 million to $400 million. The increased Revolving Credit Facility will be used in line with the Company's proposed financing strategy, and in accordance with the investment policy total borrowings will not exceed 30% of Net Asset Value1.

In addition to the increase of the commitment, certain terms of the Revolving Credit Facility have been amended. These amended terms include:

Β· Drawings under the facility will be denominated in US dollars. This will provide a partial natural hedge against FX movements as the majority (89% as at 31 March 2020) of the Company's Catalogues are acquired in US dollars and the majority of income is received in US dollars; and

Β· The Revolving Credit Facility includes three financial covenants:

o the Loan to Value, calculated as the total indebtedness of the Company divided by the gross value of its Catalogues, must not exceed 40%;

o the Company's cash and facility headroom must be greater than an estimate of one year's total costs; and

o total indebtedness of the Company as a multiple of the Net Publisher Share2 of income from the Company's Catalogues must not exceed 4.5x.

The Company will substantially invest the net proceeds of the recent equity fund raise before drawing further leverage.

1 the value of the Gross Assets of the Company less its liabilities (including accrued but unpaid fees) determined by the Directors in their absolute discretion in accordance with the accounting policies adopted by the Directors, from time to time, to be adjusted so as to reflect the fair value of intangible assets held at the relevant reporting date

2 NPS - Net publisher's share being the amount of royalties received by a music publisher less any amounts of those royalties that have to be paid to writers, performers and anyone else who receives a share of the royalties

For further information, please contact:

The Family (Music) Limited

Merck Mercuriadis

Β 

Tel: +44 (0)1481 742742

N+1 Singer - Joint Corporate Broker

James Maxwell / James Moat (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)

Β 

Tel: +44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / JΓ©rΓ©mie Birnbaum (Corporate Finance)

James Bouverat (Sales)

Β 

Tel: +44 (0)20 7742 4000

The Outside Organisation

Alan Edwards / Nick Caley

Tel: +44 (0)7711 081 843

Β 

FTI Consulting

Neil Doyle/ Paul Harris/ Laura Ewart

Β 

Β 

Tel: +44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646

Β 

All US music publicity enquiries

Fran Defeo

+1 917 767 5255

Β 

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of over Β£860 million (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019 and July 2020. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market.

About The Family (Music) Limited

The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and BeyoncΓ©, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, Nick Jarjour, David Stewart, Bill Leibowitz, Ian Montone, Jason Flom, Bjorn Lindvall and Chris Helm.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
STRSEMSIDESSELW
Date   Source Headline
14th Jul 20204:50 pmRNSPublication of Supplementary Prospectus
10th Jul 20203:51 pmRNSResult of C Share Issue
3rd Jul 20204:29 pmRNSFinal Results
3rd Jul 20207:01 amRNSDividend Declaration
2nd Jul 20207:01 amRNSPrimaryBid.com Offer
2nd Jul 20207:00 amRNSPlacing of C Shares & Date of Full Year Results
25th Jun 20206:17 pmRNSPublication of Supplmentary Prospectus
22nd Jun 20205:16 pmRNSHolding(s) in Company
12th Jun 202012:30 pmRNSDirector/PDMR Shareholding
12th Jun 20207:00 amRNSContemplation of Equity Raise & Result of EGM
4th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSUnaudited NAV and Trading Update
29th May 20203:03 pmRNSProposed Amendment to Borrowing Policy
14th May 20207:01 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSInterim Dividend Declaration
23rd Apr 20207:00 amRNSAcquisition of Music Catalogue
15th Apr 20207:00 amRNSIncreased Debt Facility
1st Apr 20204:00 pmRNSChange of Name of Administrator/Company Secretary
30th Mar 20207:00 amRNSAcquisition of Music Catalogue
25th Mar 202012:03 pmRNSPrice Monitoring Extension
23rd Mar 20205:03 pmRNSDirector/PDMR Shareholding
19th Mar 20201:56 pmRNSDirector/PDMR Shareholding
18th Mar 20202:18 pmRNSDirector/PDMR Shareholding
17th Mar 202011:36 amRNSInvestment Adviser Purchase of Shares
16th Mar 20204:04 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFTSE 250 Index Inclusion
2nd Mar 20207:00 amRNSTotal Voting Rights
26th Feb 20207:00 amRNSContemplation of Equity Raise and USD Quote
14th Feb 202011:52 amRNSDirectors' Share Holdings
7th Feb 20205:30 pmRNSHipgnosis Songs Fund
7th Feb 20207:00 amRNSNAV's, C Share Conversion and Total Voting Rights
3rd Feb 20207:00 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSAcquisition of Music Catalogue
23rd Jan 20207:00 amRNSDividend Declaration
17th Jan 20207:00 amRNSAcquisition of Music Catalogue
13th Jan 20207:00 amRNSConversion of C Shares
9th Jan 20207:00 amRNSAcquisition of Music Catalogue
7th Jan 20207:00 amRNSAcquisition of Music Catalogue
30th Dec 20197:00 amRNSPerformance Fee and Total Voting Rights
20th Dec 20197:00 amRNSAcquisition of Music Catalogue
18th Dec 20197:00 amRNSAcquisition of Music Catalogue
17th Dec 20197:00 amRNSAcquisition of Music Catalogue
16th Dec 20193:11 pmRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSAcquisition of Music Catalogue
11th Dec 20197:01 amRNSAcquisition of Music Catalogue
11th Dec 20197:00 amRNSInterim Results
10th Dec 20197:00 amRNSAcquisition of Music Catalogue
9th Dec 20194:47 pmRNSInvestor Call on 12 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.